Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Reproducibility of the 6-minute walk test for ambulatory oxygen prescription.

Chatterjee AB, Rissmiller RW, Meade K, Paladenech C, Conforti J, Adair NE, Haponik EF, Chin R Jr.

Respiration. 2010;79(2):121-7. doi: 10.1159/000220343. Epub 2009 May 20.

2.

[Efficacy of the 6-minute walk test in evaluating ambulatory oxygen therapy].

Morante F, Güell R, Mayos M.

Arch Bronconeumol. 2005 Nov;41(11):596-600. Spanish.

3.

Time to desaturation in the 6-min walking distance test predicts 24-hour oximetry in COPD patients with a PO2 between 60 and 70mmHg.

García-Talavera I, García CH, Macario CC, de Torres JP, Celli BR, Aguirre-Jaime A.

Respir Med. 2008 Jul;102(7):1026-32. doi: 10.1016/j.rmed.2008.02.004. Epub 2008 Mar 17.

4.

Detecting oxygen desaturation in patients with COPD: incremental versus endurance shuttle walking.

Sandland CJ, Morgan MD, Singh SJ.

Respir Med. 2008 Aug;102(8):1148-52. doi: 10.1016/j.rmed.2008.03.007. Epub 2008 Jun 24.

5.

Prescribing cycle training intensity from the six-minute walk test for patients with COPD.

Zainuldin MR, Knoke D, Mackey MG, Luxton N, Alison JA.

BMC Pulm Med. 2007 Jul 1;7:9.

6.

[Incidence of individualized training on exercise-induced desaturation in COPD patients].

Durand F, Delample D, Poulain M, Préfaut C.

Rev Mal Respir. 2007 May;24(5):591-8. French.

PMID:
17519810
7.
8.

Comparison between an indoor and an outdoor 6-minute walk test among individuals with chronic obstructive pulmonary disease.

Brooks D, Solway S, Weinacht K, Wang D, Thomas S.

Arch Phys Med Rehabil. 2003 Jun;84(6):873-6.

PMID:
12808541
9.

Should oxyhaemoglobin saturation be monitored continuously during the 6-minute walk test?

Fiore C, Lee A, McDonald C, Hill C, Holland A.

Chron Respir Dis. 2011;8(3):181-4. doi: 10.1177/1479972311407355.

PMID:
21799083
10.

Walking capacity and fitness to fly in patients with chronic respiratory disease.

Chetta A, Castagnetti C, Aiello M, Sergio F, Fabiano N, Tzani P, Marangio E, Olivieri D.

Aviat Space Environ Med. 2007 Aug;78(8):789-92.

PMID:
17760287
11.

The endurance shuttle walk test: an alternative to the six-minute walk test for the assessment of ambulatory oxygen.

Revill SM, Noor MZ, Butcher G, Ward MJ.

Chron Respir Dis. 2010;7(4):239-45. doi: 10.1177/1479972310378311.

PMID:
21084548
13.
14.

Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients.

Golpe R, Pérez-de-Llano LA, Méndez-Marote L, Veres-Racamonde A.

Respir Care. 2013 Aug;58(8):1329-34. doi: 10.4187/respcare.02290. Epub 2013 Jan 15.

15.

Peak power estimated from 6-minute walk distance in Asian patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.

Kozu R, Jenkins S, Senjyu H, Mukae H, Sakamoto N, Kohno S.

Respirology. 2010 May;15(4):706-13. doi: 10.1111/j.1440-1843.2010.01744.x. Epub 2010 Mar 29.

PMID:
20409022
16.

Different COPD disease characteristics are related to different outcomes in the 6-minute walk test.

Waatevik M, Johannessen A, Hardie JA, Bjordal JM, Aukrust P, Bakke PS, Eagan TM.

COPD. 2012 Jun;9(3):227-34. doi: 10.3109/15412555.2011.650240. Epub 2012 Apr 12.

PMID:
22497532
17.

6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD.

Poulain M, Durand F, Palomba B, Ceugniet F, Desplan J, Varray A, Préfaut C.

Chest. 2003 May;123(5):1401-7.

PMID:
12740254
18.

Quantitative 15 steps exercise oximetry as a marker of disease severity in patients with chronic obstructive pulmonary disease.

Kramer MR, Krivoruk V, Lebzelter J, Liani M, Fink G.

Isr Med Assoc J. 1999 Nov;1(3):165-8.

PMID:
10731326
19.

Continuous oxygen monitoring--a better way to prescribe long-term oxygen therapy.

Zhu Z, Barnette RK, Fussell KM, Michael Rodriguez R, Canonico A, Light RW.

Respir Med. 2005 Nov;99(11):1386-92.

20.

Validity and reliability of the modified shuttle walk test in patients with chronic obstructive pulmonary disease.

Campo LA, Chilingaryan G, Berg K, Paradis B, Mazer B.

Arch Phys Med Rehabil. 2006 Jul;87(7):918-22.

PMID:
16813778

Supplemental Content

Support Center